Stage IB-IIIA Non-Small Cell Lung Cancer
This phase III study is for patients who have non small cell lung cancer. The pupose of this study is to find out if adding the new drug Bevacizumab (avastin) to chemotherapy improves the chance of a cure for patients who have had surgery for the removal of their lung cancer.
The study will evaluate the effects (good and bad) of a standard combination of chemotherapy drugs when given with and without the new drug, bevacizumab. The chemotherapy regimen drugs are: Cisplatin and Vinorelbine, Cisplatin and Docetaxel, Cisplatin and Gemcitabine.
Patients must undergo study specific types of lung surgery to remove the tumor with study specific staging. Patients must be recovering well from their lung surgery at least 6 weeks and up to 12 weeks before starting their study medication.
Jeffrey Schneider MD